Cannabigerol Is a Potential Therapeutic Agent in a Novel Combined Therapy for Glioblastoma

SIMPLE SUMMARY: Among primary brain tumours, glioblastoma is the most aggressive. As early relapses are unavoidable despite standard-of-care treatment, the cannabinoids delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) alone or in combination have been suggested as a combined treatment strate...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Cells
Autors principals: Lah, Tamara T., Novak, Metka, Pena Almidon, Milagros A., Marinelli, Oliviero, Žvar Baškovič, Barbara, Majc, Bernarda, Mlinar, Mateja, Bošnjak, Roman, Breznik, Barbara, Zomer, Roby, Nabissi, Massimo
Format: Artigo
Idioma:Inglês
Publicat: MDPI 2021
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7914500/
https://ncbi.nlm.nih.gov/pubmed/33562819
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cells10020340
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars